文献速递慢性肾脏病血液净化与透析

透析前肾脏病医疗护理频率与透析后死亡及住院的关联

Association of the frequency of pre-end-stage renal disease medical care with post-end-stage renal disease mortality and hospitalization.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

该研究基于美国退伍军人慢性肾脏病(CKD)透析过渡人群,分析透析前2年内联合实验室检测频率与透析后死亡和住院的关联。结果显示,更频繁的检测与较低的透析后全因死亡和住院或死亡复合风险独立相关。

要点

  • 透析前2年内联合检测频率较高者,透析后全因死亡风险更低。
  • 检测频率>12次/24个月者,透析后住院或死亡复合风险显著降低。
  • 该关联为观察性研究结果,需临床试验进一步验证。

核心结论

  • 晚期CKD患者透析前更频繁的实验室检测与透析后更好的临床结局相关。

研究设计与样本

  • 回顾性队列研究,纳入2007年10月至2011年9月间52 172名过渡至透析的美国退伍军人CKD患者,其中23 089名有透析前2年门诊实验室检测数据。

主要发现

  • 进入2年透析前期时,患者平均年龄66.2岁(SD 11.3),平均eGFR 46.8 mL/min/1.73 m²(SD 23.9)。
  • 14%的患者24个月内联合检测(肌酐、血钾、血红蛋白)少于2次,8.9%的患者检测频率高于每2个月一次。
  • 中位透析后随访2.5年期间,15 303例(66.3%)死亡,死亡率为260/1000患者年。
  • 与检测频率2-≤4次/24个月相比,>12次/24个月者的校正全因死亡风险比为0.68(95%CI 0.65-0.73),住院或死亡复合校正比值比为0.70(95%CI 0.62-0.79)。

临床怎么用

  • 在晚期CKD患者中,可考虑更频繁地监测肌酐、血钾和血红蛋白,但需临床试验验证后再推广。

局限性

  • 研究为观察性设计,无法排除残余混杂,且结果需临床试验进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have demonstrated that early pre-end-stage renal disease (ESRD) nephrology care could improve postdialysis prognosis. However, less is known about the specific types of interventions responsible for the improved outcomes. We hypothesized that more frequent predialysis laboratory testing is associated with better postdialysis outcomes in incident ESRD patients. METHODS: In all, 23 089 patients with available outpatient laboratory tests performed during the 2-year predialysis (i.e. prelude) period were identified from a total of 52 172 American veterans with chronic kidney disease (CKD) transitioning to dialysis between October 2007 and September 2011. The associations between the frequency of combined laboratory tests, including serum creatinine, serum potassium and hemoglobin (test trio), with postdialysis mortality and hospitalization were examined in multivariable adjusted Cox and logistic regression models. RESULTS: When entering the 2-year prelude period, the mean age (Standard Deviation) of the patients was 66.2 (SD 11.3) years and the mean estimated glomerular filtration rate was 46.8 (SD 23.9) mL/min/1.73 m2. In all, 14% of patients had the test trio performed less than twice in 24 months and 8.9% had the trio measured more often than every other month. Over a 2.5-year median postdialysis follow-up period, 15 303 (66.3%) patients died (mortality rate 260/1000 patient-years). The adjusted hazard ratio of all-cause mortality and adjusted odds ratio of the composite of hospitalization or death associated with lab testing done >12/24 months compared with 2-≤4/24 months were 0.68 [95% confidence interval (CI) 0.65-0.73] and 0.70 (95% CI 0.62-0.79), respectively. CONCLUSIONS: More frequent laboratory testing in patients with advanced CKD is associated with better clinical outcomes after dialysis. Further examination in clinical trials is needed before the implementation of more frequent laboratory testing in clinical practice.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Lu JL, Molnar MZ, Sumida K, et al. Association of the frequency of pre-end-stage renal disease medical care with post-end-stage renal disease mortality and hospitalization. Nephrol Dial Transplant. 2018. PMID: 29106625. doi:10.1093/ndt/gfx192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。